BD BBL™ Sensi-Disc™ Colistin 10 µg 231278Recalls & reported problems
Becton, Dickinson And Company · BD BBL™ Sensi-Disc™ Colistin 10 µg · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 30382902312780), received between Jul 31, 2023 and Aug 29, 2025 — classified as 5 malfunctions.
The most frequently reported specific device problem is “Inaccurate Information” (5 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Inaccurate Information5
Patient problems
- No Clinical Signs, Symptoms or Conditions5
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 29, 2025Inaccurate Information; Inaccurate Information
IT WAS REPORTED PRIOR TO USING BD BBL¿ SENSI-DISC¿ COLISTIN - 10 G, THE BOX CONTAINED A DIFFERENT PRODUCT THAN WAS INDICATED BY THE LABEL. THERE WAS NO REPORT OF PATIENT IMPACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22920393 ↗MalfunctionAug 27, 2025Inaccurate Information; Inaccurate Information
IT WAS REPORTED PRIOR TO USING BD BBL¿ SENSI-DISC¿ COLISTIN - 10 G, THE BOX CONTAINED A DIFFERENT PRODUCT THAN WAS INDICATED BY THE LABEL. THERE WAS NO REPORT OF PATIENT IMPACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22902139 ↗MalfunctionAug 27, 2025Inaccurate Information; Inaccurate Information
IT WAS REPORTED PRIOR TO USING BD BBL¿ SENSI-DISC¿ COLISTIN - 10 G, THE BOX CONTAINED A DIFFERENT PRODUCT THAN WAS INDICATED BY THE LABEL. THERE WAS NO REPORT OF PATIENT IMPACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22902138 ↗MalfunctionAug 27, 2025Inaccurate Information; Inaccurate Information
IT WAS REPORTED PRIOR TO USING BD BBL¿ SENSI-DISC¿ COLISTIN - 10 G, THE BOX CONTAINED A DIFFERENT PRODUCT THAN WAS INDICATED BY THE LABEL. THERE WAS NO REPORT OF PATIENT IMPACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22902136 ↗MalfunctionJul 31, 2023Inaccurate Information; Inaccurate Information
IT WAS REPORTED THAT PRIOR TO USING BD BBL¿ SENSI-DISC¿ COLISTIN - 10 ¿G, FIVE BOXES ARRIVED WITH INCORRECT LABEL INFORMATION. NO PATIENT IMPACT REPORTED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "CUSTOMER ORDERED BD 231278 DISC COLISTIN CL-10 HOWEVER THEY RECEIVED BD 230749 INSIDE THE BOX. SAME LOT NUMBER AND EXPIRY DATE HOWEVER THEY HAVE DIFFERENT BD ITEM/SKU NUMBER BASED ON THE BOX AND ITS ACTUAL PRODUCT INSIDE."
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17424585 ↗
Other SUSCEPTIBILITY TEST DISCS, ANTIMICROBIAL devices
- BD BBL Sensi-Disc Ampicillin 2 ug 231263Becton, Dickinson And Company · SUSCEPTIBILITY TEST DISCS, ANTIMICROBIAL2 recalls0 reports
- BD BBL™ Sensi-Disc™ Ciprofloxacin 5 µg 231658Becton, Dickinson And Company · SUSCEPTIBILITY TEST DISCS, ANTIMICROBIAL1 recall2 reports
- BD BBL™ Sensi-Disc™ Piperacillin/Tazobactam 100/10 µg 231691Becton, Dickinson And Company · SUSCEPTIBILITY TEST DISCS, ANTIMICROBIAL1 recall1 report
- BD BBL™ Sensi-Disc™ Ceftazidime 30 µg 231633Becton, Dickinson And Company · SUSCEPTIBILITY TEST DISCS, ANTIMICROBIAL1 recall1 report
- BD BBL™ Sensi-Disc™ Levofloxacin 5 µg 231706Becton, Dickinson And Company · SUSCEPTIBILITY TEST DISCS, ANTIMICROBIAL1 recall1 report
- BD BBL™ Sensi-Disc™ Cefepime 30 µg 231696Becton, Dickinson And Company · SUSCEPTIBILITY TEST DISCS, ANTIMICROBIAL1 recall1 report
- BD BBL™ Sensi-Disc™ Chloramphenicol 30 µg 231274Becton, Dickinson And Company · SUSCEPTIBILITY TEST DISCS, ANTIMICROBIAL1 recall0 reports
- BD BBL™ Sensi-Disc™ Cefotaxime 30 µg 231607Becton, Dickinson And Company · SUSCEPTIBILITY TEST DISCS, ANTIMICROBIAL1 recall0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page